On Wednesday, Feb. 25, 2026 HYDRINITY Accelerated Skin Science revealed a groundbreaking clinical study by the Journal of Cosmetic Dermatology that demonstrates how its novel retinal encapsulated in biomimetic exosomes significantly improved the appearance of photodamaged skin, with no product-related irritation reported.
In a 12-week clinical study (HRET-1224), 20 women aged 35–65 with mild-to-moderate photodamage applied the HYDRINITY RetaXome™ Daily Retinal Hydrator nightly, showing progressive improvement at every evaluation point through week 12.
Related: Indermal Launches Vegan DDS Pure Retinal with Encapsulated Delivery
Erythema (Redness)
- Statistically significant reduction at every follow-up visit, with mean erythema improved by 68% at week 12 compared to baseline.
Skin Tone
- Noticeable evening of tone observed as early as week 2 and an overall improvement of 56% by week 12.
Skin Texture
- Progressive texture improvement throughout the study period and an overall 63% improvement from baseline by week 12.
Fine Lines and Wrinkles
- Statistically significant reduction at all follow-up visits, with a 36% improvement at week 12.
Participant Satisfaction
- 95% of participants were satisfied and would recommend the product, and no product-related adverse events were reported throughout the 12-week study.
"Retinal has long been recognized as one of the most effective ingredients for photoaged skin—but tolerability has remained its greatest limitation," said Dr. Michael Gold, MD, FAAD, lead investigator and board-certified dermatologist.
HYDRINITY innovation is driven by an engineered biomimetic exosome platform that encapsulates retinal for precise, controlled release and enhanced penetration. Combined with the brand's proprietary Supercharged Hyaluronic Acid and plant-derived antioxidant and anti-inflammatory actives, the formulation enhances results while supporting skin barrier integrity, establishing a new class of performance-driven skincare.
"This study marks an important milestone in the HYDRINITY mission to fuse biotechnology with advanced skincare," said Keith O'Briant, CEO of HYDRINITY.
